View in EDS

Pembrolizumab plus Lenvatinib for Synchronous Triple Primary Malignancies of the Kidney, Bladder, and Liver: Clinical Implications of Conflict of Drug Doses and Dominant Tumor Biology.

Saved in:
Bibliographic Details
Title: Pembrolizumab plus Lenvatinib for Synchronous Triple Primary Malignancies of the Kidney, Bladder, and Liver: Clinical Implications of Conflict of Drug Doses and Dominant Tumor Biology.
Authors: Atagi Y; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Fukatani Y; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Kouno R; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Seto K; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Hashine K; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Source: Case reports in oncology [Case Rep Oncol] 2026 Mar 31; Vol. 19 (1), pp. 805-814. Date of Electronic Publication: 2026 Mar 31 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 101517601 Publication Model: eCollection Cited Medium: Print ISSN: 1662-6575 (Print) Linking ISSN: 16626575 NLM ISO Abbreviation: Case Rep Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42358647
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pembrolizumab plus Lenvatinib for Synchronous Triple Primary Malignancies of the Kidney, Bladder, and Liver: Clinical Implications of Conflict of Drug Doses and Dominant Tumor Biology.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Atagi+Y%22">Atagi Y</searchLink>; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.<br /><searchLink fieldCode="AU" term="%22Fukatani+Y%22">Fukatani Y</searchLink>; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.<br /><searchLink fieldCode="AU" term="%22Kouno+R%22">Kouno R</searchLink>; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.<br /><searchLink fieldCode="AU" term="%22Seto+K%22">Seto K</searchLink>; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.<br /><searchLink fieldCode="AU" term="%22Hashine+K%22">Hashine K</searchLink>; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101517601%22">Case reports in oncology</searchLink> [Case Rep Oncol] 2026 Mar 31; Vol. 19 (1), pp. 805-814. <i>Date of Electronic Publication: </i>2026 Mar 31 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101517601 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1662-6575 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216626575%22">16626575 </searchLink><i>NLM ISO Abbreviation: </i>Case Rep Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42358647
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000551772
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 805
    Titles:
      – TitleFull: Pembrolizumab plus Lenvatinib for Synchronous Triple Primary Malignancies of the Kidney, Bladder, and Liver: Clinical Implications of Conflict of Drug Doses and Dominant Tumor Biology.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Atagi Y
      – PersonEntity:
          Name:
            NameFull: Fukatani Y
      – PersonEntity:
          Name:
            NameFull: Kouno R
      – PersonEntity:
          Name:
            NameFull: Seto K
      – PersonEntity:
          Name:
            NameFull: Hashine K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 03
              Text: 2026 Mar 31
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1662-6575
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Case reports in oncology
              Type: main
ResultId 1